Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of microRNA in castration-resistant prostate cancer.

Urologic oncology - 1 Jul 2014

Thieu William, Tilki Derya, de Vere White Ralph, Evans Christopher P

Abstract excerpt

INTRODUCTION: Castration-resistant prostate cancer (CRPC) has a historically low median survival rate, but recent advances and discoveries in microRNAs (miRNAs) have opened the potential for new prognostication modalities to enhance therapeutic success. As new chemotherapies and immunotherapies are developed, there is an increasing need for precision and stratification of CRPC to allow for optimization and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to MicroRNAs
Share to Neoplasm Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Precision Medicine

Share to Prognosis

Share to Prostatic Neoplasms, Castration-Resistant

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24935732
DOI: 10.1016/j.urolonc.2013.11.004
PMCID: PMC4570565

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of microRNA in castration-resistant prostate cancer.PMID 24935732Read ↗

The roles of microRNAs in the progression of castration-resistant prostate cancerSemantic proximity Read ↗

MicroRNA in prostate cancer: functional importance and potential as circulating biomarkersSemantic proximity Read ↗

Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancerSemantic proximity Read ↗

Therapeutic Potential of miRNAs in Prostate Cancer: From Mechanisms to Targeted Therapy and Clinical ApplicationsSemantic proximity Read ↗

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glanceSemantic proximity Read ↗

Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic networkSemantic proximity Read ↗

MicroRNAs Role in Prostate Cancer.Semantic proximity Read ↗

Gene expression profiling analysis of castration-resistant prostate cancer.Semantic proximity Read ↗

Development and prevalence of castration-resistant prostate cancer subtypesSemantic proximity Read ↗

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profilingSemantic proximity Read ↗

Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.Semantic proximity Read ↗

Progress in the mechanism and drug development of castration-resistant prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.